Literature DB >> 21881355

Emergency coronary artery bypass grafting for left main shock syndrome.

Hajime Osawa1, Toshihiro Fujimatsu.   

Abstract

OBJECTIVE: Acute myocardial infarction (AMI) complicated by cardiogenic shock and left main coronary artery disease (left main shock syndrome) shows high morbidity, and whether early coronary artery bypass grafting (CABG) improves the clinical outcome remains unclear.
METHODS: Six consecutive patients (mean age, 61.6 years) with MI complicated by left main shock syndrome underwent emergency CABG. Patients were divided into 2 groups according to the time from MI to reperfusion; within 8 hours in 3 patients and beyond 8 hours in the remaining. Average postoperative peak creatinine kinase (CK) and creatinine kinasemyosin band (CK-MB) levels were recorded, and the ejection fraction (EF) was measured with ultrasound cardiography.
RESULTS: Significant differences in postoperative EF and CPK-MB were observed between the 2 groups. The 30-day survival rate was 100%. Five patients left the hospital alive, while 1 died on postoperative day 78.
CONCLUSIONS: AMI complicated by cardiogenic shock and left main coronary artery disease can be effectively treated with emergency CABG, with acceptable mortality and morbidity. Emergency CABG for MIs within 8 hours can improve survival in patients with left main shock syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881355     DOI: 10.5761/atcs.oa.10.01645

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  2 in total

1.  Successful treatment of left main shock syndrome induced by thrombosed coronary artery dissection: A case report.

Authors:  Xiaojun Bai; Weiping Zhang; Zuyi Yuan
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

2.  Early surgical myocardial revascularization in non-ST-segment elevation acute coronary syndrome.

Authors:  Sebastian V Rojas; Mai Linh Trinh-Adams; Aitor Uribarri; Felix Fleissner; Pavel Iablonskii; Sara Rojas-Hernandez; Marcel Ricklefs; Andreas Martens; Stefan Rümke; Gregor Warnecke; Serghei Cebotari; Axel Haverich; Issam Ismail
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.